A reduction in sybII levels mimics the decline in synaptophysin expression in AD, again without an appreciable loss of synaptotagmin-1 (Shimohama et al., 1997) suggesting these two SV molecules are functionally linked. Here, SYP is linked to Alzheimer disease.